CEO Michael Herrera announced today that MHA Consulting has been retained by a groundbreaking human intelligence (HI) company developing the world’s first neuroprosthesis to mimic, repair and improve cognition to assist with the development of their business continuity management plan. “This company is at the forefront of research that will help us better understand neurological diseases and dysfunctions such as Alzheimer’s and Parkinson’s diseases, depression and anxiety,” said Herrera. “We are looking forward to working with them to ensure the continued availability of their innovative technology and research.”
MHA Consulting has been proud to serve organizations in the research sector from all over the United States for many years. This depth of experience provides us with unmatched knowledge among our peers and arms us with an understanding of the intricacies of the research arena. We look forward to being a trusted adviser to this organization, providing them with a sound foundation for risk mitigation, continuity and resiliency that that their BCM program follows the highest industry standards and best practices.
About MHA: A privately-held company located in Phoenix, Arizona, MHA is a proven leader in Business Continuity Planning, Disaster Recovery Planning, IT best practices, and data center moves. Since 1999, we have helped protect trillions of dollars in global-market assets across an expansive range of companies and industries in the United States and abroad. MHA provides Business Continuity Management services that offer solutions that assist organizations with the analysis, development, implementation, and ongoing performance of plans that ensure the availability of critical business processes and Information Technology systems. We assist our clients in maintaining continuous operation of their critical business processes and IT resources – as well as meeting compliance requirements, reducing risk, and instilling investor confidence – all through effective and efficient continuity planning and execution.